Zoe McDougall joined Oxford Nanopore in 2008 in a strategic marketing, communications and investor facing role – the first person to be hired with a specific commercial remit. She now leads the company’s strategic communications and corporate affairs functions, as Oxford Nanopore expands to engage with broader stakeholders, include from scientific researchers to governments and policymakers.
Since the foundation of the company, Zoe has driven accessible and authentic communities, communication channels and marketing processes and teams so that anyone engaging with or interested in Oxford Nanopore understands the company, their technology and their philosophy. During early commercialization, Zoe and her team drove the creation of structures and activities that enabled the building up of Oxford Nanopore’s customer community; this enables many teams at Oxford Nanopore to collaborate with our thriving user base, to improve the technology and expand the applications that it can perform. She subsequently built marketing functions and was part of the company’s IPO team.
Zoe started her career in sales and marketing at SmithKline Beecham. She subsequently worked at the strategic marketing and communications consultancy, Porter Novelli where she ran healthcare-related campaigns across a range of clinical areas for clients including GSK, BMS and Pfizer, across multiple areas including immunology, cancer, diabetes, cardiovascular and respiratory medicine.
Before joining Oxford Nanopore Zoe worked on the IPO and investor relations for a UK specialty pharma company. In 2004, she spent six months working with a medical humanitarian organisation in Sri Lanka.